BioSpace News Archive

NeuroMetrix, Inc. (Nasdaq: NURO) today announced a publication titled “Effects of Wearable Transcutaneous Electrical Nerve Stimulation on Fibromyalgia: A Randomized Controlled Trial” in the Journal of Pain Research.

Ortho Clinical Diagnostics, one of the world’s largest pure-play in vitro diagnostics companies, announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform, is now available in Canada.

Veterinary Endodontics Companies Weighs on Pet Clinics in Non-Conventional Markets

Artificial heart-lung machine, commonly known as cardiopulmonary bypass pump, is used to take the role of the heart and lungs during any cardiovascular surgical procedure.

Confocal microscope is an advanced form of widefield fluorescence+ microscopy used in the generation of high-resolution images of material stained with fluorescent probes.

This accreditation enables TFS to address complex requirements characteristic of the current clinical research environment. Flexible approach and quick implementation of change helps us reach our clinical trial goals.

One of the integral part of ophthalmic division is ophthalmic imaging. It permits the clinician to keep an observation on the findings through clinical ocular examination in an objective, transmissible, reproducible, and durable manner.

BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the launch of its Malaria project, which aims to develop a well-tolerated and highly effective Malaria vaccine and implement sustainable vaccine supply solutions on the African continent.

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System, making it more broadly available for coronary artery disease decision-making in Japan.

Nutra Pharma Corporation, a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter pain management market and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus and Pain, provided updates on their plans and progress on improving Company transparency and public company compliance.